← Back to headlines
Kiora Pharmaceuticals Reports GAAP EPS of -$0.34, Beating Estimates
Kiora Pharmaceuticals announced a GAAP EPS of -$0.34, surpassing analyst expectations by $0.28, as detailed in its latest financial report.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
